According to REGENXBIO's latest financial reports the company's current revenue (TTM ) is โฌ0.13 Billion. In 2024 the company made a revenue of โฌ80.07 Million a decrease over the revenue in the year 2023 that were of โฌ81.63 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.